抗原抗体

  • 网络SLA;ENA;EA-IgA;Human SLA;SLALP
抗原抗体抗原抗体
  1. 乙型肝炎病毒E抗原抗体系统的变化与慢性肝病预后的关系

    Study of Relationship between HBe Antigen-Antibody System and Prognosis of Chronic Hepatopathy

  2. 抗乙型肝炎病毒表面抗原抗体国产ELISA试剂评价

    Evaluation of six anti-hepatitis B surface antigen ELISA kits made in China

  3. 慢性乙型肝炎患者血清HBVdna定量检测与抗原抗体模式的关系

    Relationship between the serum HBV DNA content detection and antigen-antibody mode in patients with chronic type B hepatitis

  4. 结论MG的心脏损害可能与SH-Ab滴度增高抗原抗体结合等自身免疫机制有关。

    Conclusion The heart involvement in patients with MG may be related with the autoimmune mechanism of antigens and antibodies combination .

  5. 用表面等离子体谐振(SPR)技术测试抗原抗体结合反应

    Test the antigen-antibody binding reaction by the surface plasmon resonance technology

  6. 与Graves眼病有关的眼肌自身抗原抗体的分子免疫学研究

    Molecular Immunological Studied of Eye Muscle Autoantigens and Antibodies Related to Graves ' Ophthalmopathy

  7. 鼻咽癌病例一级亲属EB病毒壳抗原抗体的对照研究

    Antibodies against EB virus capsid antigen in the first-grader elatives of NPC patients

  8. BSA动物免疫过程抗原抗体亲和动力学特性的研究

    The Affinity Kinetics Study between Antigen and Antibody in the Process Using BSA to Immune Animals

  9. 属于非抗原抗体反应,IgE、IgG未见明显规律性变化,但体内组胺明显升高。

    It is non-antigen-antibody reaction , no significant changes in IgE and IgG , but histamine significantly increased in vivo .

  10. 目的评价6种国产抗乙型肝炎病毒表面抗原抗体(抗HBs)酶联免疫吸附试验(ELISA)试剂盒。

    Objective To evaluate the quality of six anti hepatitis B surface antigen ( anti HBs ) ELISA kits made in China .

  11. 这可能由于ELISA方法对抗原结构的影响而导致抗原抗体结合的不同。

    It may be that the antigen structure was effected by the different ELISA methods , so that the capability of the binding of antigen to antibody was changed .

  12. 双向琼脂扩散试验显示抗原抗体的结合比为1:8,间接ELISA检测到抗体效价达到1:12800。

    Double immunodiffusion test showed the antigen-antibody binding ratio to be 1:8 , and the titre of antibodies was 1 : 12 800 detected by indirect ELISA . 4 .

  13. 大鼠吸入EHFV气溶胶后体内抗原抗体的动态观察

    Dynamic Observation on Antigen and Antibody in Rats Inhaled EHFV Aerosol

  14. 目的探讨前S2抗原抗体系统检测的临床意义。

    Objective To explore the clinical significance of detecting hepatitis B virus PreS 2 antigen and PreS 2 antibody .

  15. 抗体在体内体外中和hCG生物活性的能力;3.抗原抗体亲和常数的测定。

    The capacity of hCG antibodies in vitro and in vivo and 3 . the binding affinity constants of hCG antibodies were assayed .

  16. 酶免疫检测(EIA)技术,是根据抗原抗体反应具有高度的特异性,将酶标记物的抗体作为标准试剂来鉴定未知的抗原。

    Based on high specificity of antigen-antibody reaction , enzyme immunoassay ( EIA ) identified unknown antigen by antibody labelled with enzyme as standard reagent .

  17. [目的]探讨子宫内膜样腺癌细胞中线粒体肌酸激酶(CK鄄mit)、抗凋亡基因Bax和细胞核抗原抗体Ki鄄67的表达及其在子宫内膜样腺癌诊断中的意义。

    To investigate the diagnostic significance of expression of mitochondrial creatine kinase ( CK-mit ), Bax gene and anti-Ki-67 nuclear antigen ( Ki-67 ) in endometrioid adenocarcinoma .

  18. 方法Lp(a)采用酶免疫比浊法、LDL-C采用抗原抗体直接测定法。

    Methods Turbidimetric enzyme immunoassay and antigen-antibody complexes direct assay were used for the quantitative determination of serum Lp ( a ) and LDL-C respectively ;

  19. 但不能解离AChE与3F3构成的抗原抗体复合物.结论:电鳐AChE活性中心负矩部位构成其活性中心构象抗原决定簇的一部分。

    CONCLUSION : Anionic subsite of the active center of Torpedo AChE constructs a part of its conformational epitope .

  20. 运用PEG6000沉淀法清除血清标本中的抗原抗体复合物;

    X Clearance of antigen-antibody complex in serum samples by PEG-6000 precipitation .

  21. 应用抗人Ⅷ因子相关抗原抗体,抗VEGF单克隆抗体,采用ABC免疫组化法,分别检测45例胃癌组织中MVD和VEGF的表达水平。

    The MVD and the expression of VEGF in the samples of gastric cancers were assayed by using immunohistochemical methods of SABC with human factor ⅷ related antibody , the VEGF monocolonal antibody .

  22. 利用H2O2将抗原抗体结合的电位响应信号放大采用直接电位法检测IgG的浓度。

    After enlarging the signal of the combination of antigen and antibody by H 2O 2 , the concentration of IgG is able to be measured by testing the electrode potential directly .

  23. 通过分析酶标抗体稀释液对反应结果的影响,发现不含BSA的稀释液更有利于抗原抗体特异性反应。

    After analysing the influence of enzyme-labeled antibody diluents on the reaction between antigen and antibody , it was found that the diluent without BSA was more suitable for the specific reaction .

  24. 结果表明,融合目的基因在HeLa细胞获得表达,S/2SS融合蛋白具有比S/SS融合蛋白更强的SS抗原抗体反应性。

    The result showed that the recombinant gene could be expressed in HeLa cells , and the SS immunogenicity of S / 2 SS fusion protein was higher than that of S / SS fusion protein .

  25. 通过抗原抗体的特异性结合将抗体连到电极表面,再将辣根过氧化物酶(HRP)标记羊抗小鼠IgG与抗体反应从而将其连到电极表面。

    Then , antibody was immobilized on the electrode by specific reaction between antigen and antibody . The horseradish peroxidase ( HRP ) labeled anti-mouse IgG secondary antibody was bound to the antibody on the electrode surface .

  26. 目的:观察鼻咽清毒颗粒加鼻渊舒口服液对鼻咽癌高危人群EB病毒壳抗原抗体VCA/IgA的抑制作用。

    OBJECTIVE : To investigate the effect of application of bi yan qing du ke li combined with nasosinusitis relieving oral liquid on EB virus VCA / IgA titers in patients with the high risk of nasopharyngeal carcinoma ( NPC ) .

  27. [目的]观察鼻咽清毒颗粒合用鼻渊舒口服液对鼻咽癌患者放疗后EB病毒壳抗原抗体VCA/IgA滴度水平和鼻咽部症状的作用。

    [ Purpose ] To investigate the effect of Bi Yan Qing Du granule combined with Bi Yuan Shu oral liquid on the titers of EB virus VCA / IgA and on nasopharyngeal symptoms in patients with nasopharyngeal carcinoma ( NPC ) after radiotherapy .

  28. 明确我国胃癌高、低发区普通人群中幽门螺杆菌(Hp)感染儿童抗CagA及其他Hp特异性抗原抗体的差异。

    Background / Aims : To study the seroprevalence of antibody to CagA in Helicobacter pylon ( HP ) infected children from the areas with high and low gastric cancer ( GC ) prevalence as to determine if CagA is a predictive marker of GC in China .

  29. 方法:采用特异性抗原抗体检测结核病患者IIPC,同时测定患者血清CIC及补体成分C3、C4水平。

    Methods : The specific antigen and antibody were used to detect IIPC of the patients with tuberculosis , at the same time , the serum circulating immune complex ( CIC ) and C 3 , C 4 levels were determined .

  30. 提纯大鼠肝GPT酶蛋白,免疫家兔后,用抗原抗体反应证明酯甲的降酶机理可能与抑制肝内GPT活力有关。

    The transaminase of rat liver was purified and immunized to rabbits . By means of antigen-antibody reactions , lowering of the activity of serum GPT was found to be due to inhibition of the activity of the liver enzyme by the drug .